Equities

Evaxion A/S

  • Add to watchlist
  • Add to portfolio
  • Add an alert
EVAX:NAQ

Evaxion A/S

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)3.18
  • Today's Change-0.13 / -3.93%
  • Shares traded17.87k
  • 1 Year change+21.37%
  • Beta0.2867
Data delayed at least 15 minutes, as of Feb 12 2026 16:22 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Evaxion A/S, formerly known as Evaxion Biotech A/S, is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.

  • Revenue in USD (TTM)7.65m
  • Net income in USD-5.42m
  • Incorporated2008
  • Employees46.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
IGC Pharma Inc1.11m-6.45m24.15m70.00--2.86--21.83-0.078-0.0780.01340.0880.110.548926.0215,800.00-64.10-51.04-81.62-56.8846.2043.57-582.82-1,150.020.889--0.0165---5.50-20.7745.22---35.93--
Marker Therapeutics Inc4.69m-14.30m24.34m5.00--1.33--5.18-1.23-1.230.36831.100.2876--3.90938,996.00-87.60-57.72-110.67-69.11-----304.54-761.28----0.00--99.0698.6323.60------
Regentis Biomaterials Ltd0.00-5.20m24.34m-----------1.00-1.000.00-1.870.00-------1,548.81--------------------------226.60------
LAMY0.00106.70k24.50m--25.51--201.80--0.01370.01370.00-0.00450.00------763.23-----------------------67.39--299.15------
Boundless Bio Inc0.00-61.76m24.85m64.00--0.2256-----16.06-16.060.004.920.00----0.00-35.93---38.37--------------0.00-------32.22------
Aeon Biopharma Inc0.00-3.00k24.99m5.000.2136--320.32--4.874.870.00-1.710.00----0.00-0.0471-----------------5.95--------110.92------
Rallybio Corp674.00k-14.17m25.14m15.00--0.3959--37.29-2.55-2.550.120312.020.0092----26,960.00-19.32-40.97-21.16-43.42-----2,102.37-42,838.52----0.00------22.52------
Cue Biopharma Inc7.10m-37.68m25.33m41.00--1.89--3.57-0.4553-0.45530.08230.17030.1857--4.01173,170.70-98.58-60.20-170.74-73.56-----530.75-683.99----0.1107--69.1621.8419.83--7.32--
IO Biotech Inc0.00-88.35m25.58m80.00--27.20-----1.34-1.340.000.01310.00----0.00-136.03-58.51-184.96-64.76------------0.9482-------10.93------
Evaxion A/S (ADR)7.65m-5.42m26.23m46.00------3.43-16.88-16.882.18--------166,326.10---96.54---126.06-----70.88-2,792.25--------4,480.82--52.24------
Exicure Inc0.00-9.23m27.09m8.00--3.91-----3.07-3.070.001.090.00----0.00-71.27-44.45-94.78-60.08-------259.52----0.00-----17.3442.65------
Raphael Pharmaceutical Inc0.00-1.40m27.48m0.00---------0.0723-0.07230.00-0.06440.00-------4,831.04-----------------86.56---------13.02------
VolitionRX Ltd1.47m-22.88m27.52m85.00------18.70-0.229-0.2290.0147-0.3160.1539--4.7417,317.88-241.07-122.29---283.19-----1,566.40-5,826.45---15.03----59.10135.3023.65--2.34--
Passage Bio Inc0.00-45.26m27.85m60.00--0.8948-----14.47-14.470.009.790.00----0.00-48.69-49.32-61.70-53.58------------0.00------36.54---54.23--
Dyadic International Inc3.34m-7.35m28.79m6.00--11.04--8.61-0.2371-0.23710.10770.0720.2974--5.27557,033.30-65.38-46.12-89.89-51.9631.5435.01-219.86-335.59---34.440.6579--20.5815.7714.51------
Data as of Feb 12 2026. Currency figures normalised to Evaxion A/S's reporting currency: US Dollar USD

Institutional shareholders

2.90%Per cent of shares held by top holders
HolderShares% Held
Ikarian Capital LLCas of 30 Sep 202580.00k1.27%
PSM Verm�gensverwaltung GmbH Langen v.d.Goltz, Dr. Prinzas of 28 Nov 202550.00k0.79%
Boothbay Fund Management LLCas of 30 Sep 202523.73k0.38%
WesBanco Bank, Inc. (Investment Management)as of 31 Dec 202510.00k0.16%
RhumbLine Advisers LPas of 30 Sep 20259.44k0.15%
GAMMA Investing LLCas of 31 Dec 20253.84k0.06%
UBS Securities LLCas of 31 Dec 20253.22k0.05%
EverSource Wealth Advisors LLCas of 31 Dec 20252.71k0.04%
SBI Securities Co., Ltd.as of 31 Dec 202562.000.00%
Bessemer Investment Management LLCas of 31 Dec 202518.000.00%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.